Are you interested in getting involved in Irish Research?
There are many diabetes-related research studies going on in Ireland and they regularly seek people with diabetes or members of their family to take part.
From 2017 we will be featuring a list of studies that have gained ethical approval and are taking place now in Ireland and have been submitted to Diabetes Ireland by the research team.
COS-DAP: Developing a core outcome set for diabetes after pregnancy prevention – Diabetes After Pregnancy (DAP) often occurs in the years that follow a pregnancy complicated by Gestational Diabetes Mellitus (GDM). Many research groups are working to develop and test DAP prevention strategies. These large and long studies require lots of funding to study the relationship between prevention strategies and DAP occurring. Smaller, shorter studies tend to use outcomes other than DAP occurring to figure out if they are effective and different studies often measure different outcomes, making it difficult to compare results. Core Outcome Set (COS) projects work to create a list of essential outcomes that need to be measured in studies to ensure the results can be used effectively.
Patient Narrative Project – Your Voice Matters-The Patient Narrative Project (Your Voice Matters) was initiated in 2016 through the Clinical Strategy and Programmes Division, HSE to position the voice of patients and service users centrally in the design and implementation of Integrated Care through the four Integrated Care Programmes (ICPs). Your Voice Matters is one way of collecting and using the voices and experiences of patients, service users and their carers and families to design and improve health services across all healthcare settings. Your Voice Matters is particularly interested in hearing about the experiences of people living with chronic conditions.
How can pharmacists develop patient-pharmacist communication skills? – An opportunity to ask if you would like to take part in some research for the School of Pharmacy, RCSI, about how pharmacists can learn to communicate with patients. Interested in learning what YOU think might work and about YOUR experiences communicating with pharmacists, in various settings.
Strive Study – The aim of this study is to investigate the effectiveness and cost-effectiveness of Saxenda in the obesity clinic settings with a protocol for targeted use of the medication in patients who are “early” and “good” responders to the treatment. This approach is expected to minimise the side-effects and unnecessary exposure of those who will not achieve significant weight loss with the drug, optimise the costs of the medications and target the patients who will benefit more from its use.
COMPAR-EU COMPAR-EU is a multi-method, multi-component, inter-disciplinary project funded within the EU programme for Research, Horizon 2020. COMPAR-EU will contribute to bridging the gap between current knowledge and practice on self-management interventions or SMIs
Study on Type 2 diabetes using Diabetes Smart Diabetes Smart is an interactive online educational programme that will help you to understand what you can do to control your own diabetes
the Type 1 Family Experience This research is investigating how young people (11-17 years) learn to manage type 1 diabetes and how young people and their parents communicate about self-management responsibilities for type 1 diabetes.
ProACT: A new technology designed to help people living with more than one chronic health condition. This research tests if ProACT can track the different medications, symptoms, tasks, and provide the knowledge they need to help them to manage their health.
Assessment of the views of people with chronic conditions about their Healthcare. This study is investigating the patient view on healthcare products (pumps, medication) to try to better understand the ‘patient voice’ and improve the decision-making that goes into developing these products.
Structured Education Programmes for Type 2 Diabetes. This study is investigating the factors and outcomes associated with attendance at structured education programmes in adults with Type 2 diabetes
SUSTAIN 8: Efficacy and safety of semaglutide versus canagliflozin as add-on to metformin in subjects with type 2 diabetes. This trial is looking at the addition of either a once-weekly injectable medication or a tablet for people with type 2 diabetes taking metformin only, to see if blood glucose control can be further improved. Weight loss, quality of life and other safety measurements will also be investigated.
Exercise combined with protein for improving glucose control in type 2 diabetes. This study is investigating whether combining exercise and protein supplementation improve your ability to regular blood sugar after a meal.